Colinz Laboratories Share Price
Small Cap | Pharmaceuticals and health care | BSE: 531210
₹60.06 
2.86 (5.00 %)
Last Updated: 13 Mar 2025 12:00 AM
BEARISH
Overview
Open (₹) 60.00
High (₹) 60.06
Low (₹) 60.00
Prev. Close (₹) 57.20
Volume 931
VWAP (₹) 46.43
ROCE (%) 7.49
Industry P/E 43.95
TTM P/E 31.45
P/B Ratio 1.69
Market Cap (₹) Cr.15.13
Dividend Yield (%)--
EPS (₹) 1.93
ROE5.43%
Sales Growth (%) -1.75
Profit Growth (%)6.41
Day Range
60.0660.06
52 Week Range
36.0084.40
Historical Returns
Returns (6M)
-2.18 %
Returns (1Y)
49.78 %
Returns (3Y)
121.22 %
Returns (5Y)
572.56 %
Returns (6M)
-2.18 %
Returns (1Y)
49.78 %
Returns (3Y)
121.22 %
Returns (5Y)
572.56 %
SWOT Analysis
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Price above the pivot point indicates bullish sentiment.
- Price above EMA and SMA (50) indicates bullish momentum.
Technicals
Technical Rating
BEARISHRSI 39.20
MFI 25.88
ATR 2.40
Commodity Channel Index -47.48
ROC125 -14.45
ROC21 -20.71
Williams %R -69.30
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 46.71 | 47.49 | 47.88 | 46.32 | 45.54 | 45.15 | 44.37 |
| Week Ago | 44.04 | 45.44 | 46.21 | 43.27 | 41.87 | 41.10 | 39.70 |
| Month Ago | 59.71 | 62.42 | 64.84 | 57.29 | 54.58 | 52.16 | 49.45 |
EMA & SMA
60.06
Current Price
Bullish Moving Averages
20
Bearish Moving Averages
0
5 Day 44.47
9 Day 45.05
10 Day 45.32
12 Day 47.38
14 Day 47.93
20 Day 50.27
26 Day 51.64
50 Day 57.46
100 Day 58.19
200 Day 56.76
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| BHUPESH GUPTA | bulk | Buy | 10 Jul, 2024 | ₹80.98 | 12,731 | BSE |
Insider Trading
Corporate Actions
No corporate actions available.
Announcements
| Date | Source | Detail |
|---|---|---|
| 04 Mar, 2025 | BSE India | Pursuant to SEBI Cercular No SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated 31-12-2024 read with BSE circular 20250102-4, we are submitting herewith the Integrated Filing (Financial) for the Quarter and None Months Ended on 31-12-2024,\r\n\r\nKindly take the same on records.\r\n\r\nfor Colinz Labs ltd\r\nAuthorized Director |
| 31 Jan, 2025 | BSE India | As required under Regulation 30 of SEBI, we are pleased to submit our Financial Unaudited Results for the Quarter and None Months Ended on 31-12-2024. Kindly take the same on records. |
| 31 Jan, 2025 | BSE India | We would like to inform you that, the Board of Directors of the Company at their meeting held today i.e. 31st January, 2025 has, inter alia considered and approved Unaudited Financial Results (as per IND-AS) for the quarter and nine-months ended on 31st December, 2024. |
| 13 Jan, 2025 | BSE India | COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 ,inter alia, to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company, pursuant to Regulation 29(2) & 33 of SEBI (LODR) Regulations, 2015, is scheduled to be held on Friday, 31st January, 2025 at 03.30 P.M. at the registered office of the Company at A-101,\r\n Pratik Industrial Estate, Next to Fortis Hospital, Mulund Link Road, Mumbai, Maharashtra \r\n -400078 inter-alia to consider, approve and take on record the Un-Audited Financial Results of the Company for the quarter ended 31st December, 2024. \r\n |
| 08 Jan, 2025 | BSE India | Pursuant to Regulation 13(3) of the SEBI(LODR), Regulation 2015, the Statement of Investor Complaints for the Quarter Ended on 31-12-2024.\r\n\r\nXBRL for the same have also been filed\r\n\r\nKindly take the same on records. |
| 08 Jan, 2025 | BSE India | Pursuant to Regulation 13(3) of SEBI (LODR), Regulation,2015 the Statement of Investor Grievance for the Quarter ended on 31-12-2024.\r\n\r\nKindly the note of the same. |
| 08 Jan, 2025 | BSE India | Please find the attached Certificate received form our RTA M/s. Bigshare Services Pvt Ltd in Compliance under Regulation 74(5) of SEBI (Depositories and Participants) Regulation ,2018 for the Quarter ended on 31-12-2024.\r\n\r\nKindly take the same on records |
| 02 Jan, 2025 | BSE India | As required under 15(2). of SEBI(LODR) Regulation ,2015, and other applicable provision Company claiming exemption under Regulation 15(2) a of the SEBI(LODR) Regulation, 2015. \r\n\r\nAccordingly, The Related Part Transaction Reporting for the Quarter Ended 31-12-2024 as required under Regulation 23(9) of SEBI(LODR) is not applicable to the Company. |
| 02 Jan, 2025 | BSE India | This is to inform your that as per Regulation 32 of SEBI(LODR), Regulation, 2015 and (Statement of Deviation or variation of proceeds of public issues, right issues, preferential issues , QIP) is not applicable to the Company for the Quarter ended on 31-12-2024. Kindly take the note of the same.\r\n\r\n |
| 30 Oct, 2024 | BSE India | We would like to inform you that the Board of Director in their meeting held on 30-10-2024 inter alia considered and approve the Unaudited Financial Results for the Quarter Ended 30-9-2024. Kindly take the same on records. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 14 Jan, 2025 | 31 Jan, 2025 |
| Quarterly Results | -- | 15 Oct, 2024 | 30 Oct, 2024 |
| Others | Inter-alia, 1. To Consider and approve the Director's Report for the year ended 31st March, 2024. 2. To Consider and approve the Management Discussion Report, Corporate Governance Report. | 02 Aug, 2024 | 08 Aug, 2024 |
| Quarterly Results | -- | 19 Jul, 2024 | 31 Jul, 2024 |
| Quarterly Results | -- | 07 May, 2024 | 29 May, 2024 |
| Quarterly Results | -- | 11 Jan, 2024 | 31 Jan, 2024 |
| Quarterly Results | -- | 17 Oct, 2023 | 31 Oct, 2023 |
| Quarterly Results | -- | 18 Jul, 2023 | 31 Jul, 2023 |
| Audited Results | -- | 04 May, 2023 | 27 May, 2023 |
| Quarterly Results | -- | 13 Jan, 2023 | 28 Jan, 2023 |
Share Holding Pattern
| Owner Name | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 | Sept, 2023 |
|---|
About Colinz Laboratories
Colinz Laboratories is a Public Limited Listed company incorporated on 06/10/1986 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24200MH1986PLC041128 and registration number is 041128. Currently company belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 7.03 Cr. and Equity Capital is Rs. 2.52 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1986
Managing Director
-- --
NSE Symbol
--
Colinz Laboratories Management
| Name | Designation |
|---|---|
| Mr. N K Menon | Whole Time Director |
| CA. Vasant K Bhat | Independent Director |
| Mr. A Krishna Kumar | Independent Director |
| Dr. Mani L S | Non Executive Director |
| CA. Bhavik Ashokkumar Shah | Addnl. & Ind.Director |
| Mr. Baptist Bernard Dias | Addnl. & Ind.Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹4,03,916.05 | ₹1,683.45  ₹1,676.85(0.39%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,49,205.29 | ₹5,620.45  ₹5,667.15(-0.82%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,18,065.23 | ₹1,461.90 ₹1,454.30(0.52%) | ₹1,317.600 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,03,430.62 | ₹3,056.05 ₹3,096.50(-1.31%) | ₹2,488.000 - ₹3,589.950 |
| Dr. Reddy's Laboratories | ₹92,453.48 | ₹1,107.95 ₹1,105.15(0.25%) | ₹1,093.000 - ₹1,420.200 |
FAQs on Colinz Laboratories
What is the share price of Colinz Laboratories?
The share price of Colinz Laboratories on 13 Mar, 2025 is ₹ 60.06.
What is 52W high and 52W low share price of Colinz Laboratories?
The highest and lowest 52W share prices of Colinz Laboratories are ₹ 84.400 and ₹ 36.000
What is the market cap of Colinz Laboratories?
The market capitalization of Colinz Laboratories as of 13 Mar, 2025 is ₹ 15.13 Crores
What is the P/E ratio of Colinz Laboratories?
The current P/E ratio of Colinz Laboratories as of 13 Mar, 2025 is 43.95
What is the PB ratio of Colinz Laboratories?
The PB ratio of Colinz Laboratories as of 13 Mar, 2025 is 1.69
Top Gainers
₹194.70
₹162.25 (0.20%)
₹8.84
₹7.37 (0.20%)
₹6.97
₹5.81 (0.20%)
₹41.02
₹34.29 (0.20%)
Top Losers
₹0.90
₹1.10 (-0.18%)
₹2.60
₹2.94 (-0.12%)
₹9.60
₹12.00 (-0.20%)
₹123.55
₹140.00 (-0.12%)
Market Indices
Sensex
₹73,828.91
₹74,029.76 (0.00%)